Market Tracker

12/18 6:05pm ET

Transition Therapeutics Inc (NASDAQ:TTHI)

6.72
Data as of 3:55pm ET
 +0.17 / +2.60%
Today’s Change
4.36
Today|||52-Week Range
8.22
+18.10%
Year-to-Date

Today’s Trading

Previous close6.55
Today’s open6.56
Day’s range6.46 - 6.74
Volume23,579
Average volume (3 months)15,467
Market cap$231.3M
Dividend yield--
Data as of 3:55pm ET, 12/18/2014

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-16.38%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book4.17

Competitors

 Today’s
change
Today’s
% change
QTNTQuotient Ltd-0.80-5.37%
OXFDOxford Immunotec Glo...+0.40+3.45%
VCYTVeracyte Inc+0.08+1.04%
ERBERBA Diagnostics Inc-0.02-0.70%
Data as of 4:03pm ET, 12/18/2014

Financials

Next reporting dateFebruary 11, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts